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Abstract
SUMO proteins are small ubiquitin-related modifiers. All SUMOs are synthesized as propeptides that are post-translationally
cleaved prior to conjugation. After processing, SUMOs become covalently conjugated to cellular targets through a pathway
that is similar to ubiquitination. Ubiquitin like protein proteases/Sentrin specific proteases (Ulp/SENPs) mediate both
processing and deconjugation of SUMOs. The action of Ulp/SENPs makes SUMOylation a highly dynamic post-translational
modification. To investigate how Ulp/SENPs are regulated in a developmental context, we isolated and characterized all
Ulp/SENPs in Xenopus laevis. Xenopus possess homologues of mammalian SENP3, 5, 6 and 7. All of these enzymes reacted
with HA-tagged vinyl sulfone derivatives of SUMO-2 (HA-SU2-VS) but not SUMO-1 (HA-SU1-VS), suggesting that they act
primarily on SUMO-2 and -3. In contrast, Xenopus possess a single member of the SENP1/SENP2 subfamily of Ulp/SENPs,
most closely related to mammalian SENP1. Xenopus SENP1 reacted with HA-SU1-VS and HA-SU2-VS, suggesting that it acts
on all SUMO paralogues. We analyzed the mRNA and protein levels for each of the Ulp/SENPs through development; we
found that they show distinct patterns of expression that may involve both transcriptional and post-transcriptional
regulation. Finally, we have characterized the developmental function of the most abundant Ulp/SENP found within
Xenopus eggs, SENP3. Depletion of SENP3 using morpholino antisense oligonucleotides (morpholinos) caused accumulation
of high molecular weight SUMO-2/3 conjugated species, defects in developing embryos and changes in the expression of
some genes regulated by the transforming growth factor beta (TGF-b) pathway. These findings collectively indicate that
SUMO proteases are both highly regulated and essential for normal development.
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Introduction
SUMOs are among the most important and widely studied
Ubiquitin-like proteins, with diverse roles in almost every critical
aspect of nuclear function [1,2,3]. All SUMOs are synthesized as
propeptides that are processed to reveal C-terminal diglycine
motifs [4,5]. Mature SUMO proteins become covalently conju-
gated to other proteins through isopeptide linkage between their
C-termini and e-amino groups of lysines within the targets.
Budding and fission yeast both express a single SUMO protein,
while vertebrate cells express three major SUMO paralogues
(SUMO-1-3). After processing, mature SUMO-2 and -3 are
,95% identical to each other, while SUMO-1 is ,45% identical
to SUMO-2 or -3. Where they are functionally indistinguishable,
SUMO-2 and 23 will be collectively called SUMO-2/3 in this
report. Modification of proteins by SUMOylation is transient and
dynamic, due to the rapid turnover of conjugated species by
SUMO proteases. Both processing and deSUMOylation are
mediated through the action of the same family of proteases,
called Ubl specific proteases (Ulp) in yeast [6] and Sentrin-specific
proteases (SENP) in vertebrates [7]. Ulp/SENPs play a pivotal role
in determining the spectrum of SUMOylated species, since they
control both the final step in SUMO production and the half-life
of conjugated species [8,9].
Budding yeast has two Ulp/SENPs (Ulp1p and Ulp2p/Smt4p),
and mammals have six (SENP1, 2, 3, 5, 6, and 7) [9]. Sequence
alignment suggests that four mammalian SENPs (SENP1, 2, 3, 5)
fall within a Ulp1p-related sub-family, while two mammalian
SENPs (SENP6, 7) are more closely related to Ulp2p [9]. Ulp1p is
encoded by an essential gene [6]; it is important for SUMO
processing [6], 60S ribosomal particle export [10] and nuclear-
cytoplasmic trafficking [11]. Human SENP1 and SENP2 are most
closely related to each other, and can catalyze processing and
deconjugation of all SUMO paralogues [12,13,14]. Human
SENP3 and SENP5 are likewise most closely related to each
other, but they show a strong preference for processing and
deconjugation of SUMO-2/3 over SUMO-1 [15,16,17]. Ulp2p is
not essential for vegetative growth, although it is important for
sporulation [18]. Ulp2p appears to act in deconjugation [19],
especially for disassembly of poly-SUMO chains [20]. Human
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SENP6 and SENP7 show a strong preference for deconjugation of
SUMO-2/3-containing species, particularly for substrates con-
taining multiple SUMO-2/3 moieties, that may be analogous to
the activity of Ulp2p in chain disassembly [21,22].
The SUMO pathway is required for normal development
of flies [23], fish [24], mice [25], worms [26,27] and frogs
[28,29,30]. SUMOylation has been particularly implicated in
regulation of the transforming growth factor (TGF-b) pathway, a
signal transduction cascade that is central to vertebrate develop-
ment. The type I TGF-b receptor becomes SUMOylated in
rodents in response to TGF-b, enhancing the receptor’s
interactions with the Smad proteins that transduce TGF-b
pathway signals and allowing more efficient phosphorylation
and activation of Smad2/3 [31]. Smad proteins themselves are
also SUMO conjugation targets and interact with PIAS-family
SUMO ligases [32,33,34,35,36,37,38]. In Xenopus, morpholino
antisense oligonucleotides directed against the SUMO-1 mRNA
disrupt axis formation in embryos and elongation animal caps
treated with the TGF-b family member Activin [29]. The roles of
individual SUMO pathway enzymes in controlling developmental
events have not been well characterized.
To develop a better understanding of the developmental control
of Ulp/SENPs, we have cloned a comprehensive set of Ulp/
SENPs from Xenopus laevis. Interestingly, while clear homologues
exist for mammalian SENP3, SENP5, SENP6 and SENP7, there
was a single member of the SENP1/SENP2 branch of
evolutionary tree in Xenopus, which we will call SENP1 here.
SENP1 reacted with HA-tagged vinyl sulfone derivatives of both
SUMO-2 (HA-SU2-VS) and SUMO-1 (HA-SU1-VS), suggesting
that it recognizes all SUMO paralogues in a manner similar to
mammalian SENP1. By contrast, all other Xenopus SENPs showed
a strong preference for HA-SU2-VS, suggesting that they
primarily act on SUMO-2/3. We analyzed the complement of
SENPs present in eggs and early embryos, and found that SENP1,
3, 6 and 7 are detectably present in Xenopus eggs. SENP1 and 3
persisted throughout development, although there was some
variation in SENP1 levels near the midblastula transition (MBT).
SENP6 and 7 were also clearly detectable in early embryos but
declined dramatically in abundance around Stage 26 (tail bud
stage). Finally, we characterized the developmental function of the
most abundant Ulp/SENP found within Xenopus eggs, SENP3.
Depletion of SENP3 using morpholinos caused changes in the
profile of SUMO-2/3 conjugated species, defects in developing
embryos and changes in the expression of some genes regulated by
the transforming growth factor beta (TGF-b) pathway. Our
findings collectively indicate that SUMO proteases are both
differentially regulated and essential for development.
Results and Discussion
Identification of Xenopus SENPs
As a prelude to developmental analysis of the Ulp/SENPs, we
used Xenopus laevis and Xenopus tropicalis databases to identify
cDNAs and genomic sequences encoding Ulp/SENPs. We initially
found five Xenopus laevis cDNAs encoding proteins with Ulp/SENP
catalytic domains. Comparison of these sequences to mammalian
SENPs indicated that they corresponded to SENP1, 3, 5, 6 and 7
(Table 1). These assignments were similar both in the context of
the full sequences of each protein, and in the context of the
catalytic domains alone, and were also consistent with earlier
reports related to SENP proteins in Xenopus [17,30]. The most
remarkable feature of the Xenopus laevis sequences was the absence
of an apparent homologue to mammalian SENP2. We considered
the possibility that this cDNA was underrepresented within the
database. We examined the genomic sequence of a closely related
species, Xenopus tropicalis, and found that it had a similar
complement of five Ulp/SENPs that lacked SENP2. Given the
close evolutionary relationship of these two Xenopus species, it thus
appears that the absence of a cDNA encoding Xenopus laevis
SENP2 reflects the genuine absence of a corresponding gene.
Mammalian SENPs can be organized into three sets that show
pairwise sequence homology, as well as similar localization and
biochemical properties [9]. Our findings suggest that this pairwise
organization may be preserved in frogs, except in the case of the
SENP1/2 sub-family of Ulp/SENPs. The absence of a SENP2
homologue in amphibians may suggest that the paired organiza-
tion of these genes is a relatively recent feature of the evolution of
vertebrate SUMO pathway, and that amphibians diverged from
mammals before a second SENP1/2 sub-family member arose.
Alternatively, the SENP2 homologue may have been lost after the
divergence of amphibians and mammals. Two closely-related
cDNAs encoding SENP1 have been reported in Xenopus laevis,
Table 1. Characteristics of X. laevis SENPs.
X. laevis H. sapiens
Homology
Full length
(%)
Homology
Catalytic
Domain (%)
SU1-VS
Reactivity
SU-2-VS
Reactivity mRNA levels Protein levels
SENP1 (AF526893) SENP1 (BC045639) 53 80 +++ +++ Transient drop at MBT Transient drop at MBT
SENP2 (NM_021627)
SENP3 (FJ416373) SENP3 (NM_015670) 58 88 2 +++++ Present throughout
development
Present throughout
development
SENP5 (EU275408) SENP5 (NM_152699) 39 91 2 ++ Present throughout
development
Below detection
SENP6 (FJ416371) SENP6 (NM_015571) 51 61 2 ++ Present throughout
development
Decrease after stage 26
SENP7 (FJ416372) SENP7 (BC129988) 37 54 2 + Transient drop at MBT Decrease after stage 26
SENPs sequences for Xenopus laevis (X. laevis) and Homo sapiens (H. sapiens) were from Genebank database (Accession number indicated below each protein).
Homology analysis was performed using clustalw software from EMBL-EBI. The following domains were used for catalytic domain homology comparison: SENP1 (H.s.
427–644, X.l. 401–618); SENP3 (H.s. 386–574, X.l. 271–459); SENP5 (H.s. 567–755, X.l. 534–722); SENP6 (H.s. 637–1112, X.l. 641–1103); SENP7 (H.s. 662–1050, X.l. 501–901).
The reactivity of each SENP with HA-SU1-VS and HA-SU2-VS is indicated; ‘‘2’’ represents little or no adduct formation. ‘‘+’’ to ‘‘+++++’’ represents increasing percentages
of the SENP converted to adduct in three independent experiments, with the latter representing total conversion within 30 minutes. mRNA and protein levels (Stage 1
to stage 43) are summarized from data in Figure 2 and Figure 3, respectively.
doi:10.1371/journal.pone.0008462.t001
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designated xSENP1a and xSENP1b [30]. (The cDNA that we
isolated corresponds to xSENP1a.) The existence of two cDNAs
encoding SENP1 is likely reflect the pseudo-tetraploid status of the
Xenopus laevis genome [39]. The proteins encoded by these cDNAs
show a very high level of sequence similarity (88% within the
catalytic domain; 86% overall) and both are much more closely
related to human SENP1 than SENP2, making it improbable that
either of them could represent a Xenopus homologue of SENP2. As
discussed below, we observe primarily xSENP1a within early
embryos. Given that there appears to be no true SENP2 in
Xenopus, it is likely that all essential functions of mammalian
SENP2 are performed by the remaining SENPs in frogs.
Abundance and Paralogue Specificity of SENPs in
Xenopus laevis Egg Extracts
We analyzed the activity and abundance of SENPs, as well as
their paralogue specificity within Xenopus laevis egg extracts (XEEs).
This profile is useful not only because it reflects the contingent of
SENPs present in the mature egg, but also because XEEs are
valuable and well-established system that offers unique advantages
for performing in vitro biochemical and cell biological studies [40].
To determine the spectrum of SENP activity within XEEs, we
utilized vinyl sulfone derivatives of tagged SUMO-1 and -2 (HA-
SU1-VS and HA-SU2-VS; [41]), which covalently and specifically
react with the nucleophilic cysteine residue within the active sites
of SUMO proteases. HA-SU1-VS or HA-SU2-VS was added to
interphase XEEs. Vinyl sulfone reaction products were identified
by Western blotting with antibodies against the HA tag (Figure 1A).
The signal of individual bands on these Western blots reflects the
relative abundance of the corresponding SENP proteins because
HA-SU1-VS and HA-SU2-VS react with Ulp/SENPs in a
manner that is both quantitative and irreversible.
The HA-SU1-VS reaction showed a single prominent band,
with an apparent molecular weight of 90 kD (Figure 1A). The HA
tag allowed affinity purification of this reaction product, which was
subjected to SDS-PAGE. The region of the gel corresponding to
this band was excised and digested with trypsin. The resulting
peptides were subjected to mass spectrometry and the band was
identified as SENP1 (Figure 1B; Figure S1). The peptides that we
observed corresponded to the coding sequence of xSENP1a, which
we will continue to call SENP1 throughout the remainder of this
report. We did not find peptides unique to xSENP1b, and so were
unable to validate its expression. However, the absence of such
peptides does not exclude the possibility that xSENP1b may be
present at some level.
Our finding suggests that XEEs have a single major SUMO-1-
specific protease, SENP1, which falls into the SENP1/2 subfamily
as the mammalian Ulp/SENPs with strongest activity against
SUMO-1 [9]. Long exposures of the affinity purified material
showed weak bands of mobilities that might be consistent with the
Figure 1. Abundance and paralogue preference of Ulp/SENP in XEEs. (A) XEEs were incubated with buffer (left), HA-SU1-VS (middle) or HA-
SU2-VS (right), and subjected to SDS-PAGE and immunoblotting with anti-HA antibodies. Free SUMO vinyl sulfones and adducts with individual
SENPs are indicated. (B) XEEs were incubated with buffer (left lanes), HA-SU1-VS (middle lanes) or HA-SU2-VS (right lanes). HA-tagged proteins were
purified by affinity chromatography, resolved on SDS- PAGE and visualized by Silver staining (left panel) or by immunoblotting with anti-HA
antibodies (right panel). Bands recognized by the anti-HA antibodies were identified by mass spectrometry as indicated to the right of each panel. ‘‘*’’
indicates that SENP7 was not identified by mass spectrometry, but could be readily detected by immunoblotting with an antibody specific to SENP7.
(C) In vitro translated Flag-SENP5 and Flag-SENP5-C/S were incubated with HA-SU1-VS or HA-SU2-VS. The reactions were monitored by
immunoblotting with anti-HA (Upper panel) or anti-Flag (Lower panel) antibodies. ‘‘&’’ indicates the position of SENP1-VS in the upper panels. Arrow
indicates the position of unreacted Flag-SENP5 or Flag-SENP5-C/S.
doi:10.1371/journal.pone.0008462.g001
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formation of adducts between SENP6 or SENP3 and HA-SU1-
VS. If so, the fact that these bands are much weaker than
corresponding adducts in the HA-SU2-VS sample indicates
inefficient recognition of SUMO-1 by these enzymes, consistent
with the pattern observed in mammalian cells [22]. Incubation
with HA-SU2-VS showed a much higher level of reactivity, with
predominant band with an apparent molecular weight of 83 kD,
and weaker bands with apparent molecular weighs of 123 and
144 kD (Figure 1A). Analysis of these samples after affinity
purification of HA-tagged material showed that these bands
corresponded to SENP3, SENP6 and SENP7, respectively. The
sample also contained detectable amounts of SENP1 (Figure 1B).
These findings are consistent with the strong SUMO-2/3
paralogue preference previously reported for mammalian SENP3,
SENP6 and SENP7 [17,21,22].
SENP5 was the single SENP that we had found by sequence
analysis but that we did not detect in XEEs as a HA-SU1-VS or
HA-SU2-VS reaction product. We raised antibodies against
SENP5 (Figure S2), and did not find detectable amounts of
SENP5 by Western blotting of XEEs (data not shown), further
suggesting that the levels of this protein are very low in unfertilized
eggs. To determine the paralogue preference of Xenopus SENP5,
we incubated an in vitro translated, Flag-tagged SENP5 with HA-
SU1-VS and HA-SU2-VS (Figure 1C). Anti-Flag Westerns
showed a decreased mobility of the Flag-SENP5 upon incubation
with HA-SU2-VS. This band was also reactive with anti-HA
antibodies, indicating that it corresponds to the Flag-SENP5
adduct with HA-SU2-VS. Notably, a mutant version of SENP5 in
which an active site cysteine had been changed to serine did not
show a similar form with reduced mobility, indicating that the
appearance of this form required SENP5 to be catalytically active.
We did not observe the formation of an adduct upon incubation of
Flag-SENP5 with HA-SU1-VS, indicating that it had little
reactivity toward this paralogue. These findings are completely
consistent with earlier observations that mammalian SENP5 has a
strong preference for SUMO-2/3 [15,16,17], and indicate that
this preference is conserved amongst vertebrates.
Developmental Patterns of Xenopus laevis SENPs
We examined the profile of expression for each of the SENP
proteins in staged whole Xenopus laevis embryos by RT-PCR
(Figure 2). We observed two distinct patterns of mRNA
abundance: Three of the SENPs (SENP3, 5, 6) were relatively
constant in abundance relative to a control mRNA that is
constitutively expressed during early frog development (Histone
H4). By contrast, two Ulp/SENPs (SENP1, SENP7) showed
dramatic changes in abundance at the midblastula transition
(MBT), a period during Xenopus development at which the cell
cycle is remodeled, many maternal mRNAs are degraded and
zygotic transcription is initiated [42,43]. Our findings regarding
SENP1 mRNA abundance are largely consistent with an earlier
report [30], which showed decreased levels of SENP1 mRNAs
slightly before the MBT. The levels of other SENP mRNAs have
not been reported. This finding indicates that mRNAs encoding
individual Xenopus SENPs are differentially regulated during early
development.
To determine whether SENP protein levels are likewise
regulated, we examined changes in their levels both by Western
blotting and by reactivity with vinyl methyl ester derivatives of
tagged SUMO-1 and -2 (HA-SU1-VME and HA-SU2-VME;
[44]). In all cases, actin was used as a loading control to assure that
equivalent amounts of protein were loaded in each lane. In a
manner similar to their vinyl sulfone counterparts, HA-SU1-VME
and HA-SU2-VME react specifically and covalently with active-
site cysteine thiol residues of Ulp/SENPs (Figure 3). As expected,
the pattern of HA-SU2-VME reactivity found in unfertilized eggs
was very similar to the pattern observed for HA-SU2-VS
(Figure 3A). The band corresponding to SENP3 remained
prominent through Stage 43 of development (prefeeding tadpole)
[45]. Consistent with this finding, antibodies against Xenopus
SENP3 recognized a protein on Western blots that persisted
through Stage 43. This band could be confirmed to be a SUMO-
2/3 specific protease because it clearly shifted upon incubation
with HA-SU2-VME (Figure 3B) although not with HA-SU1-VME
(data not shown).
SENP6 and SENP7 showed patterns similar to SENP3,
although the levels of these proteins were initially lower, as judged
by HA-SU2-VME reactivity (Figure 3). Interestingly, SENP6 and
SENP7 decreased in abundance around Stage 26 (tail bud stage),
with SENP6 levels dropping slightly before SENP7; both proteins
were below detection by Stage 39. On the other hand, we did not
see a substantial level of SENP5 expression during early Xenopus
development. No band corresponding to SENP5 became apparent
on blots of HA-SU2-VME reactive products using anti-HA
Figure 2. RT-PCR assay showed that mRNA levels for different
SENPs family proteins vary during developmental stages. Total
RNA from whole animals at the indicated stages was analyzed by RT-
PCR using specific primers for different SENPs and Histone H4 (control).
The interval corresponding to the midblastula transition (MBT) is
indicated by the arrow. UF indicates samples from unfertilized eggs,
while individual stages are indicated numerically, proceeded by the
abbreviation St.
doi:10.1371/journal.pone.0008462.g002
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Figure 3. Developmental regulation of Xenopus SENP levels. For all panels, bands corresponding to unreacted SENPs are indicated with
the full name of each protein. SENPs within adducts are indicated with the following abbreviations: S1 = SENP1. S3 = SENP3. S6 = SENP6.
S7 = SENP7. SUMO moieties within adducts are indicated with the following abbreviations: SU1 = SUMO-1. SU2 = SUMO-2. UF indicates samples
from unfertilized eggs, while individual stages are indicated numerically, proceeded by the abbreviation St. (A) Equal amount of protein from
embryos of the indicated stages were incubated with excess HA-SU2-VME. Reactions were subjected to SDS-PAGE and Western blotting with
anti-HA or -Actin antibodies. ‘‘&’’ indicates unidentified bands. (B) Equal amount of protein from embryos of the indicated stages were incubated
with excess HA-SU2-VME (right panels) or without HA-SU2-VME (left panels). The reactions were subjected to SDS-PAGE and Western blotting
with anti-SENP3, SENP5, SENP6 and SENP7 antibodies. While we did not observe detectable bands on the blot with the anti-SENP5 antibodies, in
vitro translated Flag-SENP5 was clearly recognized by this antibody (additional lane in right panel). (C) Equal amount of protein from embryos of
the indicated stages were incubated with excess HA-SU1-VS. Reactions were subjected to SDS-PAGE and Western blotting with anti-HA or -Actin
antibodies. ‘‘&’’ Indicates unidentified bands. (D) Equal amount of protein from embryos of the indicated stages were incubated with excess HA-
SU2-VME (right panel), HA-SU1-VS (lower left panel) or without addition (upper left panel). The reactions were subjected to SDS-PAGE and
Western blotting with anti-SENP1 antibodies.
doi:10.1371/journal.pone.0008462.g003
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antibodies (Figure 3A). Moreover, although polyclonal antibodies
against Xenopus SENP5 could clearly recognize in vitro translated
SENP5, Western blots did not show substantial levels at any stage
(Figure 3B). Thus, much lower levels of SENP5 protein were found
during development even though its mRNA was constitutively
present.
The most prominent HA-SU1-VME reaction product corre-
sponded to SENP1 (Figure 3C). It is possible that minor bands
corresponded to SENP1 breakdown products or that they resulted
from reaction with other SENPs. However, Western blots with
antibodies against other SENPs showed no significant shift toward
reduced mobility forms upon incubation with HA-SU1-VME
(data not shown), indicating that the bulk of these proteins had not
formed adducts with HA-SU1-VME. The SENP1-HA-SU1-VME
adduct consistently showed a dip in abundance around Stage 11
(gastrula), but returned higher levels during Stage 15-26, in
parallel with modulations of its mRNA. Consistent with this
finding, antibodies against SENP1 recognized a band that showed
adduct formation with HA-SU1-VME as well as HA-SU2-VME
(Figure 3D), and that showed a comparable variation in
abundance during development. SENP1 protein abundance
declined after Stage 26.
These findings collectively indicate that individual Xenopus
SENP proteins are differentially regulated during early develop-
ment. Some of them (SENP1, SENP3 and SENP6) showed
correspondence between the mRNA and protein levels through
Stage 26. Changes in SENP1 mRNA and protein levels around
the MBT were particularly striking, and may suggest that SENP1
undergoes turnover and re-synthesis around this time. While the
SENP7 mRNA showed changes in abundance that were similar to
the SENP1 mRNA, SENP7 protein levels did not change in close
parallel. After Stage 26, SENP1, SENP6 and SENP7 protein levels
all declined (Figure 3), despite the persistence of corresponding
mRNAs. It is thus possible that these SENPs are subject to post-
transcriptional regulation during later development. Taken
together, our data show that individual SENPs were differentially
regulated during embryogenesis, in patterns that could involve
both transcriptional as well as posttranscriptional mechanisms.
Developmental Requirement for SENP3
Given that SENP3 was the most abundant SUMO protease in
early embryos, we wished to determine how SENP3 expression
might contribute to development. To address this question, we
utilized morpholinos to knockdown expression of SENP3 protein.
Morpholinos are synthetic oligonucleotides that have enhanced
stability by virtue of the fact that they have morpholines rather
than ribose rings within their backbone [46]. Embryos injected
with control morpholinos (Control-MO) showed normal levels of
SENP3 at Stage 39, as assessed by Western blotting with anti-
SENP3 antibodies, while embryos injected with morpholinos
directed against SENP3 mRNA (SENP3-MO) showed a dramatic
decrease in SENP3 levels (Figure 4A). Western blotting of these
embryos with antibodies against SUMO-2/3 showed a corre-
sponding increase in the levels of high molecular weight
conjugated species, while antibodies against SUMO-1 did not
show detectably altered patterns, indicating that the loss of SENP3
causes a substantial shift in the abundance of SUMO-2/3 but not
SUMO-1 conjugates (Figure 4B). This observation is consistent
with the in vitro paralogue preference of SENP3 (Figure 1; Table 1).
We assessed whether this loss of SENP3 caused any change in
early embryonic development. At Stage 39, around 90% SENP3-
MO-injected embryos showed deformities in body structures,
ocular structures or both (Figure 4C). In comparison, less than
30% of Control-MO-injected embryos showed similar deformities.
Considering these features separately: 31% of control embryos
showed defects in body structure. The level of body defects was
enhanced roughly two-fold in the SENP3-MO-injected embryos,
to around 61% (Figure 4D). A more dramatic difference was
observed in eye development; only 9% of the Control-MO-
injected embryos showed ocular defects. By contrast, 77% of the
SENP3-MO-injected embryos showed ocular defects, roughly a
8.5-fold increase over the control group (Figure 4D). We were not
able to rescue the developmental defects of SENP3-MO-injected
embryos through microinjection of mRNA encoding SENP3.
Interpretation of our results may therefore be limited by some
possibility that the SENP3-MO also disrupts the expression of
other mRNAs. More likely, however, this failure to rescue may
reflect a requirement for high levels of SENP3 protein expression
or for precise regulation of SENP3 expression that could not be
recapitulated by the exogenous mRNA. Despite these limitations,
our findings collectively suggest that SENP3 is essential for the
maintenance of an appropriate spectrum of SUMOylated species
during early development, and they are consistent with the notion
that disruption of this spectrum has severe consequences for
developing embryos, particularly for ocular structures.
Disruption of Gene Regulation in SENP3-Depleted
Embryos
Given the links between SUMOylation and the TGF-b pathway
[32,33,34,35,36,37,38], we speculated that the defects we observed
in eye development might reflect disregulation of this signaling
cascade. We used quantitative real time PCR (qRT-PCR) of RNA
from Stage 39 embryos to examine changes in expression of TGF-b
pathway components and target genes in response to SENP3
depletion. We observed downregulation of signaling components
within pathways controlled by the Bone Morphogenic Proteins
(BMPs) (Figure 5): BMPs are the largest group of proteins within the
TGF-b superfamily, and they have been particularly implicated in
eye development [47]. We examined the expression of BMP4,
which is expressed in forming Xenopus retina [48], and observed that
its abundance and mRNAs encoding Smad signaling components
(Smad1, Smad4) associated with the BMP pathway were sensitive
to SENP3 depletion. Consistent with a downregulation of BMP4-
mediated signaling, expression of the BMP4 targets Msx1 [49] and
Vent1 [50] were decreased. Comparable levels of a control mRNA
(ornithine decarboxylase (ODC)) in Control-MO- and SENP3-
MO-injected embryos indicated that the effect of SENP3 depletion
on the BMP4, Smad1, Smad4, MSX1 and Vent1 mRNAs was not
due to a general loss of mRNA transcription or global mRNA
destabilization,
Our findings support a role for SENP3 in enhancing the
expression of BMP4 pathway targets, acting at one or multiple
steps in the BMP4 pathway (Figure 5B). While these findings may
help to account for the developmental phenotypes of SENP3-
depleted embryos, they do not provide a direct mechanism of
action for SENP3 in this pathway. It remains possible that the
action of SENP3 might be relatively indirect, as other aspects of
gene expression and particularly ribosome biogenesis are likely to
be altered under these circumstances [17].
Summary
Our observations provide a profile of Ulp/SENP expression
and specificity through early vertebrate development in Xenopus
laevis, showing that these enzymes are differentially regulated at the
mRNA and protein levels (Figure 2, 3). We have further shown
that the most abundant Ulp/SENP, SENP3, is particularly
important for eye development, possibly through regulation of
BMP signaling (Figure 4, 5). Cumulatively, these observations
SUMO Proteases in Xenopus
PLoS ONE | www.plosone.org 6 December 2009 | Volume 4 | Issue 12 | e8462
suggest that the SUMO pathway is developmentally regulated,
and that the activity of individual Ulp/SENPs may play relatively
specific roles during embryogenesis.
Materials and Methods
Chemicals and Reagents
Horseradish peroxidase (HRP) conjugated secondary antibodies
(donkey anti-rabbit IgG and sheep anti-mouse), and NHS-
Sepharose and Protein-A Sepharose were from Amersham
Biosciences (Piscataway, NJ). Goat anti-rat IgG HRP conjugated
secondary antibody was from Pierce Chemical (Rockford, IL), goat
anti-Rat monoclonal anti-HA (3F10) was from Roche Diagnostic
Corporation (Indianapolis, IN), mouse anti-flag M2 and anti-Actin
antibodies were from Sigma-Aldrich Corporation (St. Louis, MO).
All other reagents were obtained from Sigma-Aldrich Corporation
(St. Louis, MO) unless otherwise stated.
SENP cDNAs and Reverse Transcription-Polymerase Chain
Reaction (RT-PCR)
Accession numbers for Xenopus laevis cDNAs corresponding to
Ulp/SENPs were: SENP1: AF526893; SENP3: FJ416373;
SENP5: EU275408; SENP6: FJ416371; SENP7: FJ416372.
For analysis of mRNA levels (Figure 2), RT-PCR was
performed as described [51]. Total RNA was prepared at the
indicated stages using TRIZOL reagent (Invitrogen, Carlsbad,
CA). RT-PCR was performed according to the supplier’s
instructions with 200 ng of total RNA as the template, by using
Super-Script One-Step RT-PCR with Platinum Taq (Invitrogen).
RT-PCR products were run on 2% agarose gels, visualized with
ethidium bromide staining under UV lights, and photographed
with Kodak imaging system (Gel Logic 100 Imaging System,
Kodak, New Haven, CT).
Primers were as follows: SENP1 59GATTTCATAGTTTCTC-
TAGTCGTATTT39 and 59CAGGAAACTGAAAGTTGAAGGC39
Figure 4. SENP3 is essential for development of Xenopus laevis embryos. (A) One cell embryos were injected with morpholinos, and
subsequently harvested at Stage 39. Equal amounts of protein from Control-MO (left) or SENP3-MO (right) embryos were subjected to SDS-PAGE and
Western blotting with anti-SENP3 or -actin antibodies. (B) Samples as in (A) were subjected to SDS-PAGE and Western blotting with anti-SUMO-2 and
–SUMO-1 antibodies, as indicated. Note the substantial accumulation of high molecular weight SUMO-2-conjugated species after SENP3 knockdown,
while there is essentially no change in SUMO-1 conjugates. (C) Morphological defects of SENP3-MO injected embryos were categorized according to
defects in body patterning and eye development, as indicated (lower three panels). The morphology of embryos injected with Control-MO is shown
in the upper panel. (D) Quantitation of morphological body deformities of SENP3-MO injected embryos. Bars indicate standard error of the mean
values. p values are indicated.
doi:10.1371/journal.pone.0008462.g004
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[30]. SENP3 59CTGCAGACGCTCGAAATAGAGAAG39 and
59AGCGCTTGTACAGACCCCAGTATAG39. SENP5 59AAAG-
CAGATGATTGGTCAGAAGATG39 and 59AATGTTTTTCAAG-
GAAATGGGTTTT39. SENP6 59TTGGATCGATCTCAGTCA-
AAGAAAG39 and 59TTTCTCCAAGCTTTTTACTGGTTCC39.
SENP7 59-AAAGCAGATGATTGGTCAGAAGATG39 59AAGT-
CATACGGCACTTCTTCACTTG39. Histone H4 (loading control)
59CGGGATAACATTCAGGGTATCACT39 and 59ATCCATGGC-
GGTAACTGTCTTCCT39 [51].
Antibodies and Immunological Methods
Rabbit anti-Xenopus SENP3 antibodies were as described [17]. A
cDNA encoding a fragment of Xenopus SENP1 (amino acid 1–418)
was subcloned between the BamHI and SalI restriction sites of
pET30a. A cDNA encoding a fragment of Xenopus SENP5 (amino
acid 327–500) was subcloned between the BamHI and SalI
restriction sites of pGEX-4T1. A cDNA encoding a fragment of
Xenopus SENP6 (amino acid 1–300) was subcloned between BamHI
and SalI restriction sites of pET28a, and a cDNA encoding a
fragment of Xenopus SENP7 (amino acid 1–200) was subcloned
between the BamHI and SalI restriction sites of pET28a.
Recombinant proteins were expressed from each of these
constructs in E. coli [BL21 (DE3)] and purified over glutathione
Sepharose 4 Fast Flow beads from GE Healthcare (Piscataway,
NJ) or Ni-NTA agarose beads from Qiagen (Valencia, CA)
according to manufactures’ instructions. The recombinant pro-
teins were injected into rabbits for the production of polycolonal
antibodies (Pacific Immunology, Ramona, CA). In all cases,
antisera were purified using antigens coupled to NHS-activated
Sepharose 4 Fast Flow beads (GE Healthcare) as described
previously [52].
For immunoblotting, anti-mouse IgG–HRP was used for
FLAG- and HA-epitope and actin visualization. Anti-rabbit
HRP was used for visualization of all other antibodies. Primary
antibodies were used at a dilution of 1:1000, and secondary
antibodies were used at a dilution of 1:5000 in PBS buffer with
0.1% tween 20 and 5% skim milk.
SENP3 Morpholino Microinjection and qRT-PCR
The MO against SENP3 (CCGGATAACAGCCGTAGTG-
TCTCCC) and a standard control MO (CCTCTTACCT-
CAGTTACAATTTATA) were purchased from Gene Tools
LLC. Morpholino oligos were suspended in sterile water. Fertilized
Xenopus eggs were dejellied in 0.1x Marc’s modified ringer solution
(0.1x MMR: 0.5 mM HEPES, pH 7.6, 10 mM NaCl, 0.2 mM
KCl, 0.1 mM MgCl2, and 0.2 mM CaCl2) containing 2% L-
cysteine, washed extensively with 0.1x MMR and kept in 0.1x
MMR plus 6% Ficoll 400. One-cell embryos were injected with
9.2 nl (90 ng) of Control-MO or SENP3-MO using a Nanoinject
II (Drummond Scientific Company). Dead or abnormal embryos
were removed after 4 hours. The embryos were kept at 18uC
overnight and transferred to 0.1x MMR at room temperature
thereafter. Phenotypes were analyzed at day 3. Proteins were
extracted from whole embryos as described below and analyzed by
Western blotting, using actin as a loading control (Figure 4).
For analysis of gene expression, total RNA from three
independent samples was extracted from whole Xenopus embryos,
cDNA was prepared, and real-time quantitative RT-PCR (qRT-
PCR) was performed as described [53]. Mixed total RNA isolated
from tadpoles of all stages spanning the entire metamorphosing
period was reverse transcribed to serve as standard samples to
produce a standard curve for the quantitative PCR analysis, where
the cDNA was diluted at series of 1:1, 1:3, 1:9, 1: 27, 1:81, and
1:243. All of the quantitative PCRs were carried out with a
quantitative PCR machine (Model 7000 Sequence Detection
System; Applied Biosystems). A set of primer specific for
elongation factor-1a (EF-1a) was used as a control for RNA input
of each sample, and the expression level of the gene of interest
within each sample was normalized to that of EF-1a. Primers were
as follows: Smad1 59GTCTTGCCACCTGTCCTTGTTCCAC39
and 59GGCATATGTGGCTCGCTTGGCT39. Smad4 59CA-
GACCTTCACAAGAATGAACTGAAGC39 and 59TCTATTC-
CAGGGGATACAACTCGTTCG39. Vent1 59AGGAGGCAA-
CAGATGGAAAGGAC39 and 59TGGCATATTTGGTTGG-
GGGCAGTG39. Msx1 59ACTGGTGTGAAGCCGTCCCT39
and 59GGTCCCGGTCTCTCCCAGGT39. BMP4 59TGGA-
GATTGTCCATTTCCCTTGGC39. 59GGGGACGCAGCATG-
CTTTTGG39. ODC 59GCCATTGTGAAGACTCTCTCCAT-
T39, 59ATCCGCTCGGGGGAAACTCC39, and EF-1a: 59CTAT-
CCACCGCCAAACATCT39 and 59CCATCTCAGCAGCTT-
CCTTC39.
Analysis of SENP5 Paralogue Specificity
The plasmid for expression of Flag-tagged Xenopus SENP5 (Flag-
SENP5) was as described [17]. An inactive SENP5 lacking a
catalytic cysteine residue (Flag-SENP5-C/S) was prepared by site
mutation PCR using PfuUltra High-Fidelity DNA Polymerase (La
Figure 5. Inhibition of TGF-Beta signalling by SENP3 knock-
down. (A) One cell embryos were injected with morpholinos, and
harvested at Stage 39. The cDNA was generated from total RNA of
tadpoles. The levels of expression for the indicated mRNAs were
evaluated for Control-MO or SENP3-MO populations by qRT-PCR, and
normalized to that of the control gene, elongation factor-1a, and the
mean of the Control-MO was set to 1. One non-regulated gene,
ornithine decarboxylase (ODC), was analyzed by qRT-PCR to confirm
equivalent inputs of total mRNA. For individual genes, three
independent samples were analyzed, and all comparisons had p values
of ,0.05. (B) Schematic representation of BMP signalling. SENP3
depletion disrupts expression of BMP target genes, MSX1 and Vent1.
Asterisks indicate genes that are downregulated in the absence of
SENP3.
doi:10.1371/journal.pone.0008462.g005
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Jolla, CA) with primers 59CAGAAGAATGACAGTGACTC-
CGGTGTGTTTGTGCTTC39 and 59GAAGCACAAACACAC-
CGGAGTCACTGTCATTCTTCTG39.
Immunoprecipitation was performed as described [17].
Briefly, FLAG-SENP5 and Flag-SENP5-C/S mRNAs were
transcribed using an mMessage mMACHINE T7 kit (Ambion).
The mRNAs were translated in Xenopus Egg Extracts (XEEs)
[54]. 25 ml of the reaction was then mixed with 25 ml interphase
XEE. The mixture was diluted five-fold with buffer A (250 mM
sucrose, 2.5 mM MgCl2, 1 mM DTT, 50 mM KCl, 100 mM
HEPES pH 7.7), and clarified by centrifugation at 15,000 g for
15 min. Mouse anti-flag antibody (M2, Sigma) or non-specific
mouse IgG was added to aliquots of the clarified supernatant,
and incubated for 1 hour on ice before addition of 15 ml pre-
blocked Protein G Sepharose (GE Healthcare). After 1 hour at
4˚C with rotation, the beads were pelleted, washed with buffer
A, and eluted with 25 ml 0.1 M glycine, pH 2.3. The
precipitated proteins were subjected to SDS-PAGE, transferred
to the membrane and blotted with antibodies to Flag and HA,
respectively.
Xenopus Egg Extracts and Embryos
Xenopus laevis were purchased from Nasco Inc (Fort Atkinson,
WI). All procedures were performed according to guidelines set
by the NICHD animal use and care committee. Low-speed
extracts of Xenopus laevis eggs were prepared as described [54].
Tadpoles were obtained by in vitro fertilization, and staged as
described [45,51]. For analysis of protein levels, 6 embryos at
each stage were lysed by pipetting in 120 ml of buffer [20 mM
HEPES, pH 7.5, 5 mM KCl, 1.5 mM MgCl2, 1 mM EGTA,
10 mM b-glycerophosphate, 50 mM NaCl, 0.1% NP-40, and
protease inhibitors (5 mg/ml of each leupeptin, pepstatin and
chymostatin, and 1 mM of AEBSF)]. After centrifugation at
15,000 g for 15 min at 4uC, the proteins level of supernatant was
determined by Nanodrop (Thermo Scientific). Equal amounts of
proteins were diluted with 5x SDS-loading buffer and then
subjected to SDS-PAGE and immunoblotting, with actin as a
loading control.
HA-SUMO-VS or VME Experiments
VS derivatives of SUMO-1 and -2 were prepared and reactions
were performed as described previously [22]. 5 ng/ml HA-
SUMO-VS or VME was added to equal amounts of prepared
lysates from embryos or XEEs, and allowed to react for 30 minutes
at room temperature. The reactions were terminated by the
addition of 5x SDS sample buffer and analyzed by SDS-PAGE
and immunoblotting with the indicated antibodies. For mass
spectrometry, proteins associated with HA-SU1-VS and HA-SU2-
VS were purified using an anti-HA affinity matrix (Roche).
Proteins were eluted with 0.1 M glycine-HCl (pH 2.5) neutralized
with 1M Tris-HCl pH 8.0 containing 6 mM sodium deoxycholate
and overnight precipitated with 10% trichloroacetic acid (TCA).
TCA pellets were re-suspended in minimal volume of 0.2 N
NaOH followed by sample buffer and subjected to SDS-PAGE,
and the individual bands were cut out from gel and analyzed by
mass spectrometry.
Supporting Information
Figure S1 Identification of vinyl sulfone reaction products. A)
The table indicates SENP proteins positively identified by mass
spectrometric analysis in the first column, with GenBank
acquisiton numbers (second column) and their predicted
molecular mass (third column). For each protein, we indicate
the number of predicted peptides found within the sample that
match the theoretically calculated mass of tryptic peptides for
the given protein (fourth column). We also indicate the number
of number of predicted peptides found within the sample that
match the theoretically calculated mass of tryptic peptides
derived from HA-SU1-VS or HA-SU2-VS (fifth column). Note
that in some cases we did not find peptides derived from SUMO
proteins, although the corresponding bands were clearly
recognized by anti-HA antibodies. B) Peptides from the major
HA-SU1-VS adduct that match sequences in SUMO-1 and
SENP1 are shown in red. C) Peptides from the major HA-SU2-
VS adducts that match sequences in SUMO-2, SENP1, SENP3
and SENP6 and are shown in red. Note that SENP7 was not
sequenced in these experiments. It was identified using specific
polyclonal antibodies that recognized a HA-SU2-VS reaction
product (see Figure 1, 3).
Found at: doi:10.1371/journal.pone.0008462.s001 (0.03 MB
DOC)
Figure S2 Rabbit SENP5 antibody recognizes in vitro translated
Flag-SENP5. In vitro translated Flag-SENP5 was subjected to
immunoprecipitation from XEEs using antibodies against the
Flag or non-specific IgG. The purified proteins were subjected to
SDS-PAGE and Western blotting using anti-Flag antibodies (left
panel) or affinity purified rabbit anti-SENP5 antibodies (right
panel).
Found at: doi:10.1371/journal.pone.0008462.s002 (0.98 MB TIF)
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